Study Group: Physicians Who Implant Drug Coated Stents (EU)(?)
Council Members in this Study Group: 18
Request a survey with this Study Group
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
1. Angioseal is a very user friendly closure device which saves staff time spent with the patient and reduces he number of pseudoaneurysms, but it does not reduce the overall number of bleeding complications. 2. Angioiseal will probably continue to increase its market share in centers not moving...
1. LUCAS can effectively sustain circulation in spite of cardiac arrest through external mechanical chest compressions thus maintaining a sustenance of blood flow to the brain during CPR. 2. Effective external mechanical chest compression devices like LUCAS, offer a new tool to aid in the treatment...
1. ENDEVOR subscribes to cardiologist concerned about the saftey profile of Current DES sold in the US (Cypher and TAXUS). 2. ENDEAVOR seems to carry a higher rate of binary restenosis than Cypher, but may have a lower rate of late stent subacute thrombosis (SAT) than either Taxus or...
1. The PROMUS™ platform is a first generation DES composed of a “limus” drug and a durable polymer placed on cobalt-chromium alloy stent.2. No large randomized trial data is yet available until presentation of the SPIRIT III data, a 1400 patient randomized trial.3. PROMUS™ main niche may...
1. DES do cause a small increase in death and MI2. The risk does not level off in comparison to BMS3. DES should be used "on-label"
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Non-Academic Community Hospital or Clinic
- Academic Institution*
- Government/Military Hospital or Clinic
- Other Freestanding Healthcare Facility
Most Common Job Types:
- Physician - Attending Physician
- Physician - Division Head
- Physician - Director
- Lecturer
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms